DR Cysteamine cysteamine bitartrate: Phase IIa data

Data from a Phase IIa trial in 7 children with cystinosis showed that twice-daily DR Cysteamine effectively maintained low white blood cell cystine levels (<2 nmol half-cystine/mg protein). Furthermor...